Publications by authors named "Pamela B Conley"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12,440

Total Likes

83

Extended Reach

124,877

Social Features

23
A
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
Deborah M Siegal, John T Curnutte, Stuart J Connolly, Genmin Lu, Pamela B Conley, Brian L Wiens, Vandana S Mathur, Janice Castillo, Michele D Bronson, Janet M Leeds

December 2015

Videos about Article: user user

2 24 21 12 15 3

View All Article and Social Media Activity
S
Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease.
Saborni Chakraborty, Bowie Yik-Ling Cheng, Desmond L Edwards, Joseph C Gonzalez, David Kung-Chun Chiu, Pamela B Conley

Immunity· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin.
Sunny L Sneed, Brian B Reese, Ana Fs Laureano, Sneha Ratnapriya, Isabella Fraschilla, Pamela B Conley

J Clin Invest· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.
Matthieu Bourdin, Delphine Perrotin, Olivier Mathieu, Tristan Herve, François Depasse, Pamela B Conley

Int J Lab Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Andrew M Demchuk, Patrick Yue, Elena Zotova, Juliet Nakamya, Lizhen Xu, Pamela B Conley

Stroke· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation.
Genmin Lu, Joyce Lin, Khanh Bui, John T Curnutte, Pamela B Conley

Res Pract Thromb Haemost· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers.
Genmin Lu, Pamela B Conley, Janet M Leeds, Mark J Karbarz, Gallia G Levy

Blood Adv· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.
Oliver Grottke, Till Braunschweig, Rolf Rossaint, Necib Akman, Janet M Leeds, Pamela B Conley

Br J Anaesth· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet Alfa for Bleeding with Factor Xa Inhibitors. Reply.
Truman J Milling, Stuart J Connolly, Pamela B Conley

N Engl J Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study.
Paul A Hamlin, Ian W Flinn, Nina Wagner-Johnston, Jan A Burger, Greg P Coffey, Pamela B Conley

Am J Hematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
Stuart J Connolly, Mark Crowther, John W Eikelboom, C Michael Gibson, John T Curnutte, Pamela B Conley

N Engl J Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.
Greg P Coffey, Jiajia Feng, Andreas Betz, Anjali Pandey, Matt Birrell, Pamela B Conley

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.
Manu T Kalathottukaren, A Louise Creagh, Srinivas Abbina, Genmin Lu, Mark J Karbarz, Pamela B Conley

Blood Adv· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.
Genmin Lu, Polly Pine, Janet M Leeds, Francis DeGuzman, Pratikhya Pratikhya, Pamela B Conley

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa.
Deborah Siegal, Genmin Lu, Janet M Leeds, Mark Karbarz, Janice Castillo, Pamela B Conley

Blood Adv· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.
Matthew D Blunt, Stefan Koehrer, Rachel C Dobson, Marta Larrayoz, Sarah Wilmore, Pamela B Conley

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis.
Robert H Lee, Raymond Piatt, Pamela B Conley, Wolfgang Bergmeier

Haematologica· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
Stuart J Connolly, Truman J Milling, John W Eikelboom, C Michael Gibson, John T Curnutte, Pamela B Conley

N Engl J Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Yacine Boulaftali, A Phillip Owens, Ashley Beale, Raymond Piatt, Caterina Casari, Pamela B Conley

Arterioscler Thromb Vasc Biol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.
Hannah E Cummings, Tao Liu, Chunli Feng, Tanya M Laidlaw, Pamela B Conley

J Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.
Genmin Lu, Francis R DeGuzman, Stanley J Hollenbach, Mark J Karbarz, Keith Abe, Pamela B Conley

Nat Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Xinming Su, Desiree H Floyd, Alun Hughes, Jingyu Xiang, Jochen G Schneider, Pamela B Conley

J Clin Invest· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs.
Gillian Stephens, Ming He, Connie Wong, Marzena Jurek, Hans-Christian Luedemann, Pamela B Conley

Thromb J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial.
Dominick J Angiolillo, Robert C Welsh, Dietmar Trenk, Franz-Josef Neumann, Pamela B Conley

Circ Cardiovasc Interv· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rap1-Rac1 circuits potentiate platelet activation.
Lucia Stefanini, Yacine Boulaftali, Timothy D Ouellette, Michael Holinstat, Laurent Désiré, Pamela B Conley

Arterioscler Thromb Vasc Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis